As of 2026-04-09, the Intrinsic Value of Terns Pharmaceuticals Inc (TERN) is -4.53 USD. This TERN valuation is based on the model Peter Lynch Fair Value. With the current market price of 52.66 USD, the upside of Terns Pharmaceuticals Inc is -108.60%.
Based on its market price of 52.66 USD and our intrinsic valuation, Terns Pharmaceuticals Inc (TERN) is overvalued by 108.60%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.53 - -4.53 | -4.53 | -108.60% |
| P/E | (16.80) - (18.08) | (17.33) | -132.9% |
| DDM - Stable | (8.43) - (27.08) | (17.76) | -133.7% |
| DDM - Multi | (0.25) - (0.61) | (0.35) | -100.7% |
| Market Cap (mil) | 5,592.49 |
| Beta | 0.54 |
| Outstanding shares (mil) | 106.20 |
| Enterprise Value (mil) | 5,067.75 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.27% |
| Cost of Debt | 5.00% |
| WACC | 7.12% |